Rearrangement-mediated Cis-regulatory Alterations in Advanced Patient Tumors Reveal Interactions With Therapy
![Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy](https://cbtn-s3.imgix.net/Rearrangement-mediated_cis-regulatory_alterations_in_advanced_patient_tum.jpeg?auto=format&ixlib=react-9.0.3&w=700)
Abstract
The global impact of somatic structural variants (SVs) on gene regulation in advanced tumors with complex treatment histories has been mostly uncharacterized. Here, using whole-genome and RNA sequencing from 570 recurrent or metastatic tumors, we report the altered expression of hundreds of genes in association with nearby SV breakpoints, including oncogenes and G-protein-coupled receptor-related genes such as PLEKHG2. A significant fraction of genes with SV-expression associations correlate with worse patient survival in primary and advanced cancers, including SRD5A1. In many instances, SV-expression associations involve retrotransposons being translocated near genes. High overall SV burden is associated with treatment with DNA alkylating agents or taxanes and altered expression of metabolism-associated genes. SV-expression associations within tumors from topoisomerase I inhibitor-treated patients include chromatin-related genes. Within anthracycline-treated tumors, SV breakpoints near chromosome 1p genes include PDE4B. Patient treatment and history can help understand the widespread SV-mediated cis-regulatory alterations found in cancer.